Neratinib is used as an adjuvant therapy in people with early stage breast cancer in which HER2 is overexpressed, after the person receives treatment with trastuzumab. It is a tyrosine kinase inhibitor anticancer drug. Reference standards of Neratinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Neratinib - API Standards [catalogue_number] => PA 14 74000 [category_ids] => ,79,80,71,81,78,70,82, [chemical_name] => [weight] => 557.04 [form] => C30H29ClN6O3 [cas] => 698387-09-6 [pslug] => 698387-09-6-neratinib-api-pa1474000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 14 74000
CAS :
Molecular Formula : C30H29ClN6O3
Molecular Weight : 557.04
stdClass Object ( [pname] => Neratinib-d6 [catalogue_number] => PA STI 067320 [category_ids] => ,79,80,71,98,78,70,82, [chemical_name] => [weight] => 563.08 [form] => C30H23D6ClN6O3 [cas] => 1259519-18-0 [pslug] => 1259519-18-0-neratinib-d6-pasti067320 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 067320
Molecular Formula : C30H23D6ClN6O3
Molecular Weight : 563.08
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
